IP Verse

Methods Of Treating Fabry Disease In Patients Having A Mutation In The Gla Gene

Patent No. EP3840753 (titled "Methods Of Treating Fabry Disease In Patients Having A Mutation In The Gla Gene") was filed by Amicus Therapeutics on Jan 16, 2019. The application was issued on Jul 24, 2024.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
BRAND MURRAY FULLERApr 24, 2025BRAND MURRAY FULLER
TEVA PHARMACEUTICALSApr 23, 2025D YOUNG

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3840753

AMICUS THERAPEUTICS
Application Number
EP19703514A
Filing Date
Jan 16, 2019
Status
Granted And Under Opposition
Jun 20, 2024
Publication Date
Jul 24, 2024
External Links
Slate, Register , Google Patents